The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cardiac Glycosides as Novel Cancer Therapeutic Agents
Abstract
The class of steroid-like compounds designated cardiac glycosides includes well-known drugs such as digoxin, digitoxin, and ouabain. Their continued efficacy in treatment of congestive heart failure and as anti-arrhythmic agents is well appreciated. Less well known, however, is the emerging role of this category of compounds in the prevention and/or treatment of proliferative diseases such as cancer. New findings within the past five years have revealed these compounds to be involved in complex cell-signal transduction mechanisms, resulting in selective control of human tumor but not normal cellular proliferation. As such, they represent a promising form of targeted cancer chemotherapy. New clinical studies of their anticancer potential as single or adjuvant treatments may provide insight into these potentially valuable therapeutic options. This review focuses on recent findings on cellular pharmacology of cardiac glycosides as they relate to treatment of human cancer and attempts to explain why these agents have been overlooked in the past.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Raghavendra, P. B., Sreenivasan, Y., Ramesh, G. T., & Manna, S. K. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0626-3 · Cited by 50
RetractedRETRACTED ARTICLE: Oleandrin-Mediated Expression of Fas Potentiates Apoptosis in Tumor Cells
Sreenivasan, Y., Raghavendra, P. B., & Manna, S. K. (2006) · Journal of Clinical Immunology · doi:10.1007/s10875-006-9028-0 · Cited by 49
RetractedKaplan, J. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102201.141218 · Cited by 1,181
Schoner, W., & Scheiner-Bobis, G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00098.2007 · Cited by 456
Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function
Xie, Z. (2003) · Molecular Interventions · doi:10.1124/mi.3.3.157 · Cited by 423
Liu, J., Tian, J., Haas, M., Shapiro, J. I., Askari, A., & Xie, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002950200 · Cited by 391
FXYD proteins: new regulators of Na-K-ATPase
Geering, K. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00126.2005 · Cited by 376
Cardiotonic steroids on the road to anti-cancer therapy
Mijatovic, T., Van Quaquebeke, E., Delest, B., Debeir, O., Darro, F., & Kiss, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.06.002 · Cited by 317
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., & Newman, R. A. (2000) · PubMed · Cited by 276
Self-citationROLE OF FXYD PROTEINS IN ION TRANSPORT
Garty, H., & Karlish, S. J. D. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.131852 · Cited by 245
Digitalis-Induced Signaling by Na+/K+-ATPase in Human Breast Cancer Cells
Kometiani, P., Liu, L., & Askari, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007302 · Cited by 208
Yeh, J., Huang, W. J., Kan, S., & Wang, P. S. (2003) · The Prostate · doi:10.1002/pros.10172 · Cited by 205
Contemporary Use of Digoxin in the Management of Cardiovascular Disorders
Gheorghiade, M., van Veldhuisen, D. J., & Colucci, W. S. (2006) · Circulation · doi:10.1161/circulationaha.105.560110 · Cited by 195
Rajasekaran, S. A., Palmer, L. G., Quan, K., Harper, J. F., Ball, W. J., Bander, N. H., Soler, A. P., & Rajasekaran, A. K. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.2.279 · Cited by 193
López-Lázaro, M., Pastor, N., Azrak, S. S., Ayuso, M. J., Austin, C. A., & Cortés, F. (2005) · Journal of Natural Products · doi:10.1021/np050226l · Cited by 188
Manna, S. K., Sah, N. K., Newman, R. A., Cisneros, A., & Aggarwal, B. B. (2000) · PubMed · Cited by 184
Self-citationMijatovic, T., Roland, I., Van Quaquebeke, E., Nilsson, B., Mathieu, A., Van Vynckt, F., Darro, F., Blanco, G., Facchini, V, & Kiss, R. (2007) · The Journal of Pathology · doi:10.1002/path.2172 · Cited by 173
Stein (2000) · doi:10.1054/mehy.1999.0985 · Cited by 171
Fas/CD95 death receptor and lipid rafts: New targets for apoptosis-directed cancer therapy
MOLLINEDO, F., & GAJATE, C. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.04.002 · Cited by 161
The digitalis-like steroid hormones: New mechanisms of action and biological significance
Nesher, M., Shpolansky, U., Rosen, H., & Lichtstein, D. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.03.013 · Cited by 161
Choedon, T. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i16.2517 · Cited by 148
Newman, R. A., Kondo, Y., Yokoyama, T., Dixon, S., Cartwright, C., Chan, D., Johansen, M. J., & Yang, P. (2007) · Integrative Cancer Therapies · doi:10.1177/1534735407309623 · Cited by 146
Self-citationDigitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved
López-Lázaro, M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.1043 · Cited by 145
Frese, S., Frese‐Schaper, M., Andres, A., Miescher, D., Zumkehr, B., & Schmid, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3544 · Cited by 142
Antineoplastic Principles in Plants: Recent Developments in the Field
Hartwell, J. L., & Abbott, B. J. (1970) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60561-x · Cited by 141
CARDIAC GLYCOSIDES AND BREAST CANCER
Stenkvist, B., Bengtsson, E., Eriksson, O., Holmquist, J., Nordin, B., Westman‐Naeser, S., & EKLUND, G. A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90996-6 · Cited by 140
Digitoxin medication and cancer; case control and internal dose-response studies
Haux, J., Klepp, O., Spigset, O., & Tretli, S. (2001) · BMC Cancer · doi:10.1186/1471-2407-1-11 · Cited by 139
Watabe, M., Masuda, Y., Nakajo, S., Yoshida, T., Kuroiwa, Y., & Nakaya, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14067 · Cited by 136
Structure–cytotoxic activity relationship for the toad poison bufadienolides
Kamano, Y., Kotake, A., Hashima, H., Inoue, M., Morita, H., Takeya, K., Itokawa, H., Nandachi, N., Segawa, T., Yukita, A., et al. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00067-4 · Cited by 129
Bielawski, K., Winnicka, K., & Bielawska, A. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1493 · Cited by 126
Āyurvedic herbal drugs with possible cytostatic activity
Smit, H. F., Woerdenbag, H. J., Singh, R. H., Meulenbeld, G. J., Labadie, R. P., & Zwaving, J. H. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)01255-c · Cited by 124
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells
Johansson, S., Lindholm, P., Gullbo, J., Larsson, R., Bohlin, L., & Claeson, P. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200106000-00009 · Cited by 121
Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells
Watabe, M., Ito, K., Masuda, Y., Nakajo, S., & Nakaya, K. (1998) · Oncogene · doi:10.1038/sj.onc.1201592 · Cited by 119
Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis)
Gupta, R. S., Chopra, A., & Stetsko, D. K. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041270202 · Cited by 118
Ouabain activates signaling pathways associated with cell death in human neuroblastoma
Kulikov, A. V., Eva, A., Kirch, U., Болдырев, А. А., & Scheiner‐Bobis, G. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.04.012 · Cited by 117
Huang, Y.-T., Chueh, S., Teng, C., & Guh, J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.013 · Cited by 116
Langhans, S. A., Hu, J. G., Gopal, J., Gallemore, R. P., Ryazantsev, S., Bok, D., & Rajasekaran, A. K. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00355.2002 · Cited by 116
Han, K.-Q. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i24.3374 · Cited by 116
Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells
Kawazoe, N., Watabe, M., Masuda, Y., Nakajo, S., & Nakaya, K. (1999) · Oncogene · doi:10.1038/sj.onc.1202555 · Cited by 115
Zhang, L., Nakaya, K., Yoshida, T., & Kuroiwa, Y. (1992) · PubMed · Cited by 114
AnvirzelTM, an extract of Nerium oleander, induces cell death in human but not murine cancer cells
Pathak, S., Multani, A. S., Narayan, S., Kumar, V., & Newman, R. A. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200007000-00006 · Cited by 107
Self-citationYeh, J., Huang, W. J., Kan, S., & Wang, P. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65724-2 · Cited by 106
Chen, J., Contreras, R. G., Wang, R., Fernandez, S. V., Shoshani, L., Russo, I. H., Cereijido, M., & Russo, J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9053-3 · Cited by 96
Espineda, C. E., Seligson, D. B., Ball, W. J., Rao, J., Palotie, A. V., Horvath, S., Huang, Y., Shi, T., & Rajasekaran, A. K. (2003) · Cancer · doi:10.1002/cncr.11267 · Cited by 95
Cardiac glycosides in cancer research and cancer therapy.
Winnicka, K., Bielawski, K., & Bielawska, A. (2006) · PubMed · Cited by 92
REDUCED EXPRESSION OF beta-SUBUNIT OF NA,K-ATPASE IN HUMAN CLEAR-CELL RENAL CELL CARCINOMA
Langhans, S. A., Ball, W. J., Bander, N. H., Liu, H., Pardee, J. D., & Rajasekaran, A. K. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68629-6 · Cited by 90
Sreenivasan, Y., Sarkar, A., & Manna, S. K. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.010 · Cited by 87
Nasu, K., Nishida, M., Ueda, T., Takai, N., Bing, S., Narahara, H., & Miyakawa, I. (2005) · Molecular Human Reproduction · doi:10.1093/molehr/gah249 · Cited by 83
Oleandrin-mediated oxidative stress in human melanoma cells.
Newman, R. A., Yang, P., Hittelman, W. N., Lu, T., Ho, D. H., Ni, D., Chan, D., Vijjeswarapu, M., Cartwright, C., Dixon, S., et al. (2006) · PubMed · Cited by 81
Self-citationContreras, R. G., Flores-Maldonado, C., Lázaro, A., Shoshani, L., Flores-Benítez, D., Larré, I., & Cereijido, M. (2004) · The Journal of Membrane Biology · doi:10.1007/s00232-004-0670-2 · Cited by 77
Shiratori, O. (1967) · PubMed · Cited by 68
Bufadienolides and a New Lignan from the Bulbs of Urginea maritima.
IIZUKA, M., Warashina, T., & Noro, T. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.282 · Cited by 68
Digoxin inhibits neuroblastoma tumor growth in mice.
Svensson, Å., Azarbayjani, F., Bäckman, U., Matsumoto, T., & Christofferson, R. H. B. (2005) · PubMed · Cited by 62
Manna, S. K., Sreenivasan, Y., & Sarkar, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20555 · Cited by 61
Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process
Nasu, S., Milas, L., Kawabe, S., Raju, U., & Newman, R. A. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00263-x · Cited by 57
Self-citationRaghavendra, P. B., Sreenivasan, Y., & Manna, S. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.009 · Cited by 56
Ouabain sensitizes tumor cells but not normal cells to radiation
Lawrence, T. S. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90132-0 · Cited by 55
Overexpression of the Na+,K+-ATPase α1 Subunit Increases Na+,K+-ATPase Function in A549 Cells
Factor, P. H., Senne, C., Dumasius, V., Ridge, K. M., Jaffe, H. A., Uhal, B. D., Gao, Z., & Sznajder, J. I. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.6.2918 · Cited by 55
Hamed, A. I., Plaza, A., Balestrieri, M. L., Mahalel, U. A., Springuel, I. V., Oleszek, W. A., Pìzza, C., & Piacente, S. (2006) · Journal of Natural Products · doi:10.1021/np060228l · Cited by 50
Na+, K+-ATPase inhibitor, ouabain accentuates irradiation damage in human tumour cell lines
Verheye-Dua, F. A. A., & Böhm, L. (1998) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1998)6:3<109::aid-roi1>3.0.co;2-1 · Cited by 35
Yamada, K., Hino, K., Tomoyasu, S., Honma, Y., & Tsuruoka, N. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00044-7 · Cited by 33
Ouabain-induced cell signaling
Steven, H. (2005) · Frontiers in bioscience · doi:10.2741/1676 · Cited by 32
Antiproliferative cardenolides from Periploca graeca
Spera, D., Siciliano, T., Tommasi, N. D., Braca, A., & Vessières, A. (2007) · Planta Medica · doi:10.1055/s-2007-967133 · Cited by 32
Estradiol modulates the sodium pump in the heart sarcolemma
Džurba, A., Ziegelhöffer, A., Vrbjar, N., Styk, J., & Slezák, J. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5765-4_15 · Cited by 26
Pharmacologic Therapy of Chronic Heart Failure
Hamad, E., Mather, P. J., Srinivasan, S., Rubin, S., Whellan, D. J., & Feldman, A. M. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707040-00002 · Cited by 25
Umebayashi, C., Yamamoto, N., Nakao, H., Toi, Y., Chikahisa, L., Kanemaru, K., Masuda, T., & Oyama, Y. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.627 · Cited by 24
Cited by
Autosis and autophagic cell death: the dark side of autophagy
Liu, Y., & Levine, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.143 · Cited by 742
Novel therapeutic applications of cardiac glycosides
Prassas, I., & Diamandis, E. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2682 · Cited by 673
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624
Liu, Y., Shoji-Kawata, S., Sumpter, R. M., Wei, Y., Ginet, V., Zhang, L., Posner, B., Tran, K. A., Green, D. R., Xavier, R. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319661110 · Cited by 607
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Bagrov, A. Y., Shapiro, J. I., & Fedorova, O. V. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000711 · Cited by 532
Metadata
- Authors
- Newman, R. A., Yang, P., Pawlus, A. D., & Block, K. I.
- Venue
- Molecular Interventions
- Publisher
- CLOCKSS Archive
- Published
- 2008-02-01
- Volume
- 8
- Issue
- 1
- Pages
- 36-49
- ISSN
- 1534-0384 (ISSN-L)
- OpenAlex
- W2070358111
- Cited by
- 515
- References
- 66
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.